Skip to main content
OpenTrials

Clinical trial condition

Metastatic Pancreatic Adenocarcinoma

Explore clinical trials studying Metastatic Pancreatic Adenocarcinoma. Study availability and eligibility vary by location and protocol.

80 public trials 12 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Pancreatic Adenocarcinoma trial results

Completed

Study of Ibrutinib vs Placebo, in Combination With Nab-paclitaxel and Gemcitabine, in the First Line Treatment of Patients With Metastatic Pancreatic Adenocarcinoma (RESOLVE)

NCT02436668

Conditions
Metastatic Pancreatic Adenocarcinoma
Locations
  • Oncology Specialties, PC; Clearview Cancer Institute Huntsville, Alabama, United States
  • Arizona Center for Cancer Care Avondale, Arizona, United States
  • St. Mary's Medical Center Daly City, California, United States
  • Moores UCSD Cancer Center La Jolla, California, United States
View all 86 locations
View Trial Details
Completed

FOLFIRINOX Followed by Ipilimumab With Pancreatic Tumor Vaccine in Treatment of Metastatic Pancreatic Cancer

NCT01896869

Conditions
Diabetes Mellitus, Insulin-Dependent, 12, Digestive System Diseases, Digestive System Neoplasms, +7 more
Locations
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
  • Washington University School of Medicine St Louis, Missouri, United States
View Trial Details
Completed

Study to Evaluate Efficacy of CO-1.01 as Second Line Therapy for Gemcitabine-Refractory Stage IV Pancreatic Adenocarcinoma

NCT01233375

Conditions
Adenocarcinoma, Carcinoma, Metastatic Pancreatic Adenocarcinoma, +7 more
Locations
  • Arizona Cancer Center at University of Arizona Tucson, Arizona, United States
  • Rocky Mountain Cancer Center Denver, Colorado, United States
  • Palm Beach Institute / Collaborative Research Group Boynton Beach, Florida, United States
  • University of Miami Miami, Florida, United States
View all 13 locations
View Trial Details
Completed

Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer

NCT01360853

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • UCSD Moores Cancer Center La Jolla, California, United States
  • Desert Comprehensive Cancer Center Palm Springs, California, United States
  • Pacific Cancer Care Salinas, California, United States
  • Premiere Oncology Santa Monica, California, United States
View all 46 locations
View Trial Details

Related conditions